CX3CL1 Worsens Cardiorenal Dysfunction and Serves as a Therapeutic Target of Canagliflozin for Cardiorenal Syndrome.

导出 LinkOut

翻译打印收藏纠错

第一作者： Cankun,Zheng

第一单位： Department of Cardiology, State Key Laboratory of Organ Failure Research, Guangdong Provincial Key Laboratory of Shock and Microcirculation, Nanfang Hospital, Southern Medical University, Guangzhou, China.

作者： Cankun,Zheng ^[1] ; Wanling,Xuan ^[1] ; Zhenhuan,Chen ^[1] ; Rui,Zhang ^[2] ; Xiaoxia,Huang ^[1] ; Yingqi,Zhu ^[1] ; Siyuan,Ma ^[1] ; Kaitong,Chen ^[1] ; Lu,Chen ^[1] ; Mingyuan,He ^[1] ; Hairuo,Lin ^[1] ; Wangjun,Liao ^[1] ; Jianping,Bin ^[3] ; Yulin,Liao ^[1]

作者单位： Department of Cardiology, State Key Laboratory of Organ Failure Research, Guangdong Provincial Key Laboratory of Shock and Microcirculation, Nanfang Hospital, Southern Medical University, Guangzhou, China. ^[1] Department of Cardiology, Jiangxi Provincial People's Hospital Affiliated to Nanchang University, Nanchang, China. ^[2] Department of Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China. ^[3] National Clinical Research Center of Kidney Disease, Guangdong Provincial Institute of Nephrology, Nanfang Hospital, Southern Medical University, Guangzhou, China. ^[4]

关键词 CX3CL1 apoptosis cardiorenal syndrome cellular transition sodium glucose cotransporter 2 inhibitor

DOI 10.3389/fphar.2022.848310

PMID 35370759

发布时间 2022-04-05

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Frontiers in pharmacology

2022年13卷

848310页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

CX3CL1 Worsens Cardiorenal Dysfunction and Serves as a Therapeutic Target of Canagliflozin for Cardiorenal Syndrome.

Frontiers in pharmacology

相似文献

Frontiers in pharmacology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

CX3CL1 Worsens Cardiorenal Dysfunction and Serves as a Therapeutic Target of Canagliflozin for Cardiorenal Syndrome.

Frontiers in pharmacology

相似文献

Frontiers in pharmacology

相关期刊

检索历史清除